Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Solano

Showing results (151-160 of 273) with videos related to

Pageof 28
Sort By:
BMC Infectious Diseases|April 19, 2015
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsEric J Bow, David J Vanness, Monica Slavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational StudyJosé Luis Piñana, Ariadna Pérez, Juan Montoro, et al.
Journal of Medical Virology|June 23, 2025
Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy IndividualsÁngela Sánchez-Simarro, Diego Carretero, Brayan Grau, et al.
Biomedicines|August 28, 2025
Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID PatientsAitor Gonzaga, Gema Martinez-Navarrete, Loreto Macia, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 5, 2020
Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantationAriadna Pérez, Juan Montoro, Rafael Hernani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2024
AURORA: A New DawnGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2016
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for LymphomaNatasha Kekre, Francisco J Marquez-Malaver, Monica Cabrero, et al.
Journal of Medical Virology|November 25, 2020
Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of seraArantxa Valdivia, Ignacio Torres, Víctor Latorre, et al.
Bone Marrow Transplantation|May 7, 2020
Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donorsJuan Montoro, José Luis Piñana, Juan C Hernández-Boluda, et al.
Cytotherapy|July 1, 2017
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II studyManuel Jurado, Claudia De La Mata, Antonio Ruiz-García, et al.
Pageof 28

Showing results (151-160 of 273) with videos related to

Sort By:
Pageof 28
BMC Infectious Diseases|April 19, 2015
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsEric J Bow, David J Vanness, Monica Slavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational StudyJosé Luis Piñana, Ariadna Pérez, Juan Montoro, et al.
Journal of Medical Virology|June 23, 2025
Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy IndividualsÁngela Sánchez-Simarro, Diego Carretero, Brayan Grau, et al.
Biomedicines|August 28, 2025
Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID PatientsAitor Gonzaga, Gema Martinez-Navarrete, Loreto Macia, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 5, 2020
Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantationAriadna Pérez, Juan Montoro, Rafael Hernani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2024
AURORA: A New DawnGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2016
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for LymphomaNatasha Kekre, Francisco J Marquez-Malaver, Monica Cabrero, et al.
Journal of Medical Virology|November 25, 2020
Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of seraArantxa Valdivia, Ignacio Torres, Víctor Latorre, et al.
Bone Marrow Transplantation|May 7, 2020
Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donorsJuan Montoro, José Luis Piñana, Juan C Hernández-Boluda, et al.
Cytotherapy|July 1, 2017
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II studyManuel Jurado, Claudia De La Mata, Antonio Ruiz-García, et al.
Pageof 28